Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Morbidities in β-thalassemia intermedia across the spectrum of disease severity: A nationwide study in Türkiye

Blood (2025) 146 (Supplement 1): 1138.

https://doi.org/10.1182/blood-2025-1138

Published: 2025

Journal Articles

Challenges in hemoglobinopathy control programs: Insights from Türkiye

Blood (2025) 146 (Supplement 1): 4693.

https://doi.org/10.1182/blood-2025-4693

Published: 2025

Journal Articles

Revisiting morbidities and predictors in transfusion-dependent thalassemia: A cohort study over 10 years from the national registry of hemoglobinopathies in Türkiye

Blood (2025) 146 (Supplement 1): 4690.

https://doi.org/10.1182/blood-2025-4690

Published: 2025

Journal Articles

Multicenter propensity score matched study on allogeneic stem cell transplantation in adult sickle cell disease: Comparison of donor vs. no donor outcomes

Can Boga, Bahar Sevgili, Emel Gurkan, Suheyl Asma, Selma Unal, Naci Tiftik, Gül İlhan, Funda Kupesiz, Zeynep Karakas, Seda Gürcan, Nur Akad Soyer, Elif Kazancı, Ayse Hilal Eroglu Kucukdiller, İpek Yildiz, Mahmut Yeral, Hakan Ozdogu, Yesim Aydinok

Blood (2025) 146 (Supplement 1): 6060.

https://doi.org/10.1182/blood-2025-6060

Published: 2025

Journal Articles

Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome–positive chronic myeloid leukemia

Blood (2019) 134 (23): 2036–2045.

https://doi.org/10.1182/blood.2019000069

Published: 2019

Includes: Supplemental data

Journal Articles

Central Nervous System Fungal Infections in Children with Leukemia, Risk Factors and Outcome: A Multicentric Study

Rejin Kebudi, MD, Serap Karaman, MD, Hande Kizilocak, Zeynep Karakas, Melike Sezgin Evim, Bengü Demirag, Zuhre Kaya, Husniye Nese Yarali, Umran Caliskan, B.Sahin Karagun, Canan Albayrak, MD, Sebnem Yilmaz, Deniz Karapinar, Ekrem Unal, MD, Adalet Meral Gunes, Neryal Tahta, Zeliha Guzelkucuk, Ulker Kocak, MD, Tiraje Celkan, MD

Blood (2018) 132 (Supplement 1): 5169.

https://doi.org/10.1182/blood-2018-99-112712

Published: 2018

Journal Articles

Relation of Pancreatic Iron Overload Detected By MRI with Disorders of Glucose Metabolism and Results of Liver, Cardiac and Pitutiary MRI Among Transfusion Dependent Thalassemia (TDT) Patients in Turkey

Zeynep Karakas, Cihangir Sevimli, Nurdan Gul, Rana Comert, Memduh Dursun

Blood (2018) 132 (Supplement 1): 2350.

https://doi.org/10.1182/blood-2018-99-115356

Published: 2018

Journal Articles

Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: results from a phase 2a study

Ali T. Taher, Zeynep Karakas, Elena Cassinerio, Noppadol Siritanaratkul, Antonis Kattamis, Aurelio Maggio, Stefano Rivella, Norbert Hollaender, Bruyère Mahuzier, Brian Gadbaw, Yesim Aydinok

Blood (2018) 131 (2): 263–265.

https://doi.org/10.1182/blood-2017-06-790121

Published: 2018

Includes: Supplemental data

Journal Articles

IKZF1 Deletions at Diagnose and Relapse of Childhood B-ALL

Yücel Erbilgin, Sinem Firtina, PhD, Ozden Hatirnaz Ng, PhD, Tiraje Celkan, MD, Zeynep Karakas, MD, Seniye Sema Anak, MD, Nazan Sarper, MD, Emine Zengin, MD, Ahmet Eskazan, MD, Muge Sayitoglu, PhD, Ugur Ozbek, MD, PhD

Blood (2017) 130 (Supplement 1): 5110.

https://doi.org/10.1182/blood.V130.Suppl_1.5110.5110

Published: 2017

Journal Articles

Efficacy and Safety of Ruxolitinib in Regularly Transfused Patients with Thalassemia: Results from Single-Arm, Multicenter, Phase 2a Truth Study

Yesim Aydinok, MD, Zeynep Karakas, MD, Elena Cassinerio, MD, Noppadol Siritanaratkul, MD, Antonis Kattamis, MD, Aurelio Maggio, MD, Norbert Hollaender, PhD, Bruyère Mahuzier, Pharm D, Brian Gadbaw, MD, Ali T. Taher, MD PhD

Blood (2016) 128 (22): 852.

https://doi.org/10.1182/blood.V128.22.852.852

Published: 2016

Journal Articles

Turkish National Severe Congenital Neutropenia Registry

Blood (2016) 128 (22): 4916.

https://doi.org/10.1182/blood.V128.22.4916.4916

Published: 2016

Journal Articles

Total Oxidant and Antioxidant Capacity in Patients with Transfusion Dependent and Nondependent Beta Thalassemia

Zeynep Karakas, Yasin Yilmaz, Dolay Damla Celik, Agageldi Annayev, Selcan Demirel, Serap Erdem Kuruca

Blood (2015) 126 (23): 4573.

https://doi.org/10.1182/blood.V126.23.4573.4573

Published: 2015

Journal Articles

Efficacy and Safety of Deferasirox Across Underlying Non-Transfusion-Dependent Thalassemia Syndromes: 1-Year Results from the Thetis Study

M Domenica Cappellini, Vip Viprakasit, Yesim Aydinok, John B Porter, Yong-Rong Lai, Noppadol Siritanaratkul, Zeynep Karakas, Antonis Kattamis, Candace Wang, Zewen Zhu, Felicity Schaefer, Ali T Taher

Blood (2015) 126 (23): 3366.

https://doi.org/10.1182/blood.V126.23.3366.3366

Published: 2015

Journal Articles

Optimizing Iron Chelation Therapy with Deferasirox for Non-Transfusion-Dependent Thalassemia Patients: 1-Year Results from the Phase IV, Open-Label Thetis Study

Ali T Taher, M Domenica Cappellini, Yesim Aydinok, John B. Porter, Zeynep Karakas, Vip Viprakasit, Noppadol Siritanaratkul, Antonis Kattamis, Candace Wang, Zewen Zhu, Victor Joaquin, Marie José Uwamahoro, Yong-Rong Lai

Blood (2015) 126 (23): 2153.

https://doi.org/10.1182/blood.V126.23.2153.2153

Published: 2015

Journal Articles

Different Response Patterns to Inactivated, Subunit or Live Attenuated Vaccines in Children after Treatment for Malignancies and Bone Marrow Transplantation

Sema S Anak, Elif Erdem Ozcan, Ayse Kilic, Mustafa Onel, Ayhan Ozguven, Aysegul Unuvar, Zeynep Karakas, Gulyuz Ozturk, Ali Agacfidan, Omer Devecioglu, Leyla Agaoglu, Yurdanur Kilinc

Blood (2015) 126 (23): 5478.

https://doi.org/10.1182/blood.V126.23.5478.5478

Published: 2015

Journal Articles

Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overload

Yesim Aydinok, Antonis Kattamis, M. Domenica Cappellini, Amal El-Beshlawy, Raffaella Origa, Mohsen Elalfy, Yurdanur Kilinç, Silverio Perrotta, Zeynep Karakas, Vip Viprakasit, Dany Habr, Niculae Constantinovici, Junwu Shen, John B. Porter

Blood (2015) 125 (25): 3868–3877.

https://doi.org/10.1182/blood-2014-07-586677

Published: 2015

Includes: Supplemental data

Journal Articles

Evaluation of Early Glomerulopathy and Tubulopathy in Patients with Transfusion Dependent Thalassemia

Zeynep Karakas, Prof, Agageldi Annayev, MD, Altan Yalciner, MD, Sevinc Emre, Prof

Blood (2014) 124 (21): 4904.

https://doi.org/10.1182/blood.V124.21.4904.4904

Published: 2014

Journal Articles

Genetic and Epigenetic Profile Of Early Relapsed Childhood ALL

Yucel Erbilgin, Ozden Hatirnaz Ng, PhD, Sinem Firtina, Tiraje Celkan, Sema Anak, MD, Zeynep Karakas, MD, Aykan Ozguven, MD, Nazan Sarper, MD, Emine Zengin, MD, Emine Turkkan, MD, Didem Yalcin Atay, MD, Yuk Yin Ng, PhD, Omer Dogru, MD, Muge Sayitoglu, PhD, Ugur Ozbek

Blood (2013) 122 (21): 1380.

https://doi.org/10.1182/blood.V122.21.1380.1380

Published: 2013

Journal Articles

Deferasirox–Deferoxamine Combination Therapy Reduces Cardiac Iron With Rapid Liver Iron Removal In Patients With Severe Transfusional Iron Overload (HYPERION)

Yesim Aydinok, MD, Antonis Kattamis, MD, M Domenica Cappellini, MD, Amal El-Beshlawy, MD, Raffaella Origa, MD, Mohsen Elalfy, MD, Yurdanur Kilinç, MD, Silverio Perrotta, MD, Zeynep Karakas, MD, Vip Viprakasit, MD, Dany Habr, MD, Antje Wegener, MD, Junwu Shen, PhD, John B Porter, MD

Blood (2013) 122 (21): 2257.

https://doi.org/10.1182/blood.V122.21.2257.2257

Published: 2013

Journal Articles

Deferasirox Continues to Reduce Iron Overload in Non-Transfusion-Dependent Thalassemia: A One-Year, Open-Label Extension to a One-Year, Randomized, Double-Blind, Placebo-Controlled Study (THALASSA)

Ali T Taher, MD, John B Porter, MD, Vip Viprakasit, MD, DPhil, Antonis Kattamis, MD, Suporn Chuncharunee, MD, Pranee Sutcharitchan, MD, Noppadol Siritanaratkul, MD, Renzo Galanello, MD, Zeynep Karakas, MD, Tomasz Lawniczek, MD, Dany Habr, MD, Jacqueline Ros, PhD, Zewen Zhu, M Domenica Cappellini, MD

Blood (2012) 120 (21): 3258.

https://doi.org/10.1182/blood.V120.21.3258.3258

Published: 2012

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Morbidities in β-thalassemia intermedia across the spectrum of disease severity: A nationwide study in Türkiye

Challenges in hemoglobinopathy control programs: Insights from Türkiye

Revisiting morbidities and predictors in transfusion-dependent thalassemia: A cohort study over 10 years from the national registry of hemoglobinopathies in Türkiye

Multicenter propensity score matched study on allogeneic stem cell transplantation in adult sickle cell disease: Comparison of donor vs. no donor outcomes

Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome–positive chronic myeloid leukemia

Central Nervous System Fungal Infections in Children with Leukemia, Risk Factors and Outcome: A Multicentric Study

Relation of Pancreatic Iron Overload Detected By MRI with Disorders of Glucose Metabolism and Results of Liver, Cardiac and Pitutiary MRI Among Transfusion Dependent Thalassemia (TDT) Patients in Turkey

Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: results from a phase 2a study

IKZF1 Deletions at Diagnose and Relapse of Childhood B-ALL

Efficacy and Safety of Ruxolitinib in Regularly Transfused Patients with Thalassemia: Results from Single-Arm, Multicenter, Phase 2a Truth Study

Turkish National Severe Congenital Neutropenia Registry

Total Oxidant and Antioxidant Capacity in Patients with Transfusion Dependent and Nondependent Beta Thalassemia

Efficacy and Safety of Deferasirox Across Underlying Non-Transfusion-Dependent Thalassemia Syndromes: 1-Year Results from the Thetis Study

Optimizing Iron Chelation Therapy with Deferasirox for Non-Transfusion-Dependent Thalassemia Patients: 1-Year Results from the Phase IV, Open-Label Thetis Study

Different Response Patterns to Inactivated, Subunit or Live Attenuated Vaccines in Children after Treatment for Malignancies and Bone Marrow Transplantation

Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overload

Evaluation of Early Glomerulopathy and Tubulopathy in Patients with Transfusion Dependent Thalassemia

Genetic and Epigenetic Profile Of Early Relapsed Childhood ALL

Deferasirox–Deferoxamine Combination Therapy Reduces Cardiac Iron With Rapid Liver Iron Removal In Patients With Severe Transfusional Iron Overload (HYPERION)

Deferasirox Continues to Reduce Iron Overload in Non-Transfusion-Dependent Thalassemia: A One-Year, Open-Label Extension to a One-Year, Randomized, Double-Blind, Placebo-Controlled Study (THALASSA)

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only